The pharma giant announced that the Food and Drug Administration approved its new safety warning label for Depo-Provera — Pfizer’s birth control injection that has been a subject of controversy as ...

Depo Provera’s label change comes amidst a flurry of over 2,000 lawsuits from women alleging that the contraceptive caused ...

FDA approves Depo-Provera label warning of meningioma brain tumor risk after 1983 studies; 1,000+ women sue Pfizer for concealment as EMA, Canada already updated labels., US News, Times Now ...

See more stories on Insider's business page. A third dose of Pfizer's coronavirus vaccine yields mild to moderate side effects, much like the second shot, according to data released this month by the ...

Most people won't experience allergic reactions to the vaccine, experts insist. The Food and Drug Administration late Friday authorized Pfizer's COVID-19 vaccine for people ages 16 and up, but warned ...

(RTTNews) - Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, ...

ALBANY, N.Y. (NEWS10)- After months of anticipation, the Federal Food and Drug Administration (FDA) approved the use of Pfizer’s COVID-19 vaccine. On December 17 the FDA will vote to approve Moderna’s ...

(Reuters Breakingviews) - Pfizer has made more than its share of value-destroying acquisitions. The pharmaceutical giant's $15 billion purchase of Hospira could reverse that history. The ...

The patient, who died on December 14, was originally enrolled in a Phase III study in 2022 and transitioned into an extension phase in 2023.

A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...

WASHINGTON -- The pharmaceutical giant Pfizer tightened its policies Friday regarding the use of drugs in lethal injections, a move experts said would make it harder for states to carry out executions ...

Both vaccines are administered in two doses and have similar effective rates. After the second dose, Pfizer’s vaccine is 95% effective, Moderna’s 94.5% effective but there are many differences. The ...